Claire F. Friedman

Also affiliated with Eli Lilly (United States), Cornell University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 34 papers. Top paper: “Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study”.

Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0450

N/A

3.0DataRank · unranked

101 citations

John D. Hainsworth, Razelle Kurzrock, David R. Spigel, Howard A. Burris, Christopher J. Sweeney +9 more

Ovarian cancer mutational processes drive site-specific immune evasion

Nature(2022)10.1038/s41586-022-05496-1

N/A

0.863DataRank · unranked

314 citations

Florian Uhlitz, Nicholas Ceglia, Jamie Lim, Michelle Wu, Neeman Mohibullah +56 more

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Nature Medicine(2024)10.1038/s41591-024-02942-7

N/A

0.790DataRank · unranked

26 citations

Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula +23 more

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Gynecologic Oncology(2024)10.1016/j.ygyno.2023.12.028

N/A

0.583DataRank · unranked

12 citations

M. Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth M. Cohen +9 more

Ongoing genome doubling shapes evolvability and immunity in ovarian cancer

Nature(2025)10.1038/s41586-025-09240-3

N/A

0.553DataRank · unranked

39 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Duaa H. Al-Rawi, Matthew Zatzman, Adam C. Weiner +53 more

Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.015

N/A

0.533DataRank · unranked

34 citations

Deborah F. DeLair, Lorenzo Ferrando, Daniel Fix, Robert A. Soslow, Kay J. Park +16 more

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors

The Oncologist(2025)10.1093/oncolo/oyaf017

N/A

0.473DataRank · unranked

11 citations

Yonina R. Murciano‐Goroff, Antoine Desîlets, Guilherme Harada, Michael A. Postow, Margaret K. Callahan +9 more

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100873

N/A

0.385DataRank · unranked

12 citations

Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal +4 more

The Search for Genomic Biomarkers of Response to Immunotherapy in Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0048

N/A

0.330DataRank · unranked

8 citations

Nicole Rusk, Claire F. Friedman, Duaa H. Al-Rawi

Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.026

N/A

0.269DataRank · unranked

5 citations

Lindsey Finch, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +14 more

Induction of a CD8 T cell intrinsic DNA damage and repair response is associated with clinical response to PD-1 blockade in uterine cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.16.488552

N/A

0.269DataRank · unranked

5 citations

Sasikanth Manne, Nils Wellhausen, Derek A. Oldridge, Allison R. Greenplate, Lakshmi Chilukuri +10 more

Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2023-004842

N/A

0.165DataRank · unranked

2 citations

Victoria Wan, Michael Finlan, Qin Zhou, Alexia Iasonos, Oliver Zivanovic +14 more

Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.059

N/A

0DataRank · unranked

89 citations

Amir Momeni Boroujeni, Claire F. Friedman, Pier Selenica, Qin Zhou, Michelle Wu +16 more

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1078

N/A

0DataRank · unranked

20 citations

Vignesh Ravichandran, Kathryn Miller, Chad Vanderbilt, Qin Zhou, Alexia Iasonos +17 more

Comprehensive analysis of germline drivers in endometrial cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad016

N/A

0DataRank · unranked

21 citations

Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel +37 more

Data from Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

(2023)10.1158/1078-0432.c.6532995.v1

N/A

0DataRank · unranked

0 citations

Ying L. Liu, Kelly A. Devereaux, Arnaud Da Cruz Paula, Qin Zhou, Weining Ma +18 more

Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005522

N/A

0DataRank · unranked

9 citations

Nadeem R. Abu‐Rustum, Kaled M. Alektiar, Vicky Makker, Ying L. Liu, Dmitriy Zamarin +8 more

Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.11.602772

N/A

0DataRank · unranked

11 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Matthew Zatzman, Duaa H. Al-Rawi, Adam C. Weiner +52 more

Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.21.609031

N/A

0DataRank · unranked

7 citations

Ignacio Vázquez-Garćıa, Grittney Tam, Michelle Wu, Nancy Varice, Eliyahu Havasov +22 more

Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2024.100005

N/A

0DataRank · unranked

3 citations

Sarah Andres, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +15 more

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.023

N/A

0DataRank · unranked

2 citations

Matthew Flint, M. Herman Chui, Jason Konner, Claire F. Friedman, Angela K. Green +14 more

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.10.019

N/A

0DataRank · unranked

16 citations

Rachel N. Grisham, Karen A. Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman +14 more

Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancer

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.102712

N/A

0DataRank · unranked

0 citations

Madison Miller, Christian Dagher, Sarah H Kim, Marisa Kollmeier, Yukio Sonoda +8 more

Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100852

N/A

0DataRank · unranked

36 citations

Claire F. Friedman, Jennifer J. Mueller, Ryma Benayed, Marc Ladanyi, Maria E. Arcila +4 more

Pattern of disease and response to pembrolizumab in recurrent cervical cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100831

N/A

0DataRank · unranked

9 citations

Olga T. Filippova, Sara A. Hayes, Nadeem R. Abu‐Rustum, Carol Aghajanian, Vance Broach +14 more

High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1134

N/A

0DataRank · unranked

73 citations

Pier Selenica, Juber Patel, Michelle Wu, Josip Ninčević, Yulia Lakhman +25 more

Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0713

N/A

0DataRank · unranked

67 citations

Ying L. Liu, Kelly A. Devereaux, Arnaud Da Cruz Paula, Qin Zhou, Weining Ma +18 more

Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.003

N/A

0DataRank · unranked

48 citations

Dib Sassine, Alli Straubhar, Aaron Praiss, Carol Aghajanian, Kaled M. Alektiar +17 more

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.028

N/A

0DataRank · unranked

23 citations

Eric Rios Doria, Jason Konner, Stuart M. Lichtman, Qin Zhou, Alexia Iasonos +18 more

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101058

N/A

0DataRank · unranked

11 citations

Brooke A. Schlappe, Qin Zhou, Alexia Iasonos, Mario M. Leitão, Kay J. Park +8 more

Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101095

N/A

0DataRank · unranked

4 citations

Anastasia Navitski, Claire F. Friedman, Donald Chan, Shari Goldfarb, Mario E. Lacouture +2 more

Bifunctional Blockade: A Novel Immunotherapy Approach for Cervical Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1779

N/A

0DataRank · unranked

6 citations

Claire F. Friedman, Kathryn Miller

592 Phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: part 1 results

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0592

N/A

0DataRank · unranked

2 citations

Richard D. Carvajal, Diwakar Davar, Eduardo Castañón, Paolo A. Ascierto, Emiliano Calvo +16 more

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3135

N/A

0DataRank · unranked

0 citations

Yonina R. Murciano‐Goroff, Justin Jee, Maria E. Arcila, Darren J. Buonocore, Jianjiong Gao +15 more